Affymax, Inc. (AFFY) Message Board
-
Unless they find clear evidence of bees' stings being the culprit, such n estimations typically take months.
Sentiment: Hold
-
I think the lethality of the anaphylactic reaction may turn up to be related to the dose scale used to transition from epogen. It will be interesting as well as of course depressing to hear what Mr Irwin has to say tomorrow. It will be interesting to see if any anaphylactic reactions occurred in patients whose 1st ESA was Omontys.
Sentiment: we are screwed -
Yes. I think they are in advanced stages of partnership/acquisition talks
Sentiment: Buy
-
Cardiome 's Safety FDA 's requirement will be satisfied by European post marketing data, no need for act5 . After r/s there will be an anounncement
- Reply to
I think there must be some kind of news pending (maybe after the market) that only the insiders and MM know about
by coria_chick1 •Mar 7, 2013 1:56 PMيارب
-
licking my 92K wounds I just sold. oh well
-
the truth is, SA article for AFFY, affy goes up, SA article against affy, affy goes down, manipilators and their cronies, cat died and will bounce a few times then be still for ever and then rot. I rode this to 27 with 10K shares, never sold till yesterday, lost every penny, because of the f&^*ing lying CEO and his reassuring statements, I hope Orwin rots in hell. I should have listened to the shorts, too late. No big pharma will touch this corpse, charity is not the name of the game here. The writing is on the wall
-
speculation from the cc language, and perhaps wishful thinking
Sentiment: Buy
-
it was that point in the conference call when he said he doesn't want to reveal the contents of upcoming conference calls
- Reply to
In the conversion of AF to SR, vernakalant is highly effective without obviously raised side effects.
by sternjon •Mar 19, 2013 10:36 AMyes this drug is gold, that's why I lost 400K of gains in it after the act5 halt and all the other drama with Merck. That's why no big pharma will touch it and the FDA won't approve it
Sentiment: Hold
-
1.05
-
Yes I am dumb
-
I think one way of looking at that would be an expression of confidence by the company. The CEO sounded confident about something uplifting to follow the consolidation. He hinted at that in the conference call. Perhaps something good is in store??
-
Manipulation?
-
Oh well
Sentiment: Hold
-
Are we halted for some reason ?
-
I think the reason is the lack of good news in the CEO update. I think his tone was very wishful and uncertain a out prospects. The investment community has lost interest completely in cardiome for reasons that are obvious and also for reasons that are not obvious to us commoners. Not a single question was asked after the cc. My expectations after this cc was that crme will trade sideways or drop until we have a truly significant update. I am not sure to this day why Merck lost faith in this molecule? And why the previous chairman quit? And why on earth were they recruiting patients for ACT 5 in Peru where the safety mishap occurred leading to the halt. The revival of Vernakalant as Hunter hopes to happen is a long long shot. I am a believer in the molecule and have paid dearly for my faith in it. I am beginning to have more doubts about prospects here though and the cc did not alleviate them but rather exacerbate my doubts. I am keeping my 20 k shares for now and hoping and praying for a miracle and that whatever the company and Merck and the FDA Know that we don't know is not a as bad a it seems.
Sentiment: Hold
-
What a joke, zero volume, off 7% so far, no interstellar from individual or mm investors. No posts. A flat line performance. Wow.
Sentiment: Hold
-
I think that Adasuve could potentially be very useful to control unruly passengers on airplanes and used also by law enforcement to subdue agitated subjects?? Better than a taser gun ??
Sentiment: Hold